Reported 0 shares, down 1 (100.0%) from the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 0 |
| 2022-03-31 | 0 |
| 2022-06-30 | 0 |
| 2022-09-30 | 0 |
| 2022-12-31 | 38 |
| 2023-03-31 | 15 |
| 2023-06-30 | 15 |
| 2023-09-30 | 9 |
| 2023-12-31 | 7 |
| 2024-03-31 | 8 |
| 2024-06-30 | 7 |
| 2024-09-30 | 6 |
| 2024-12-31 | 7 |
| 2025-03-31 | 6 |
| 2025-06-30 | 5 |
| 2025-09-30 | 2 |
| 2025-12-31 | 0 |
| 2026-03-31 | 0 |
| 2026-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Reduced | 0 | -1 (-100.0%) | 0 | $0 | 2026-08-05 | |
| Q1 2026 | New | 1 | +1 (0.0%) | 0 | $0 | 2026-05-07 | |
| Q4 2025 | Reduced | 0 | -1 (-100.0%) | 0 | $0 | 2026-02-11 | |
| Q3 2025 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $2 | 2025-11-13 | |
| Q2 2025 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $5 | 2025-07-08 | |
| Q1 2025 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $6 | 2025-04-08 | |
| Q4 2024 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $7 | 2025-02-10 | |
| Q3 2024 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $6 | 2024-11-13 | |
| Q2 2024 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $7 | 2024-08-08 | |
| Q1 2024 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $8 | 2024-05-06 | |
| Q4 2023 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $7 | 2024-02-12 | |
| Q3 2023 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $9 | 2023-11-14 | |
| Q2 2023 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $15 | 2023-08-04 | |
| Q1 2023 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $15 | 2023-04-25 | |
| Q4 2022 | Reduced | 1 | -49 (-98.0%) | < 0.01% | $38 | 2023-02-06 | |
| Q3 2022 | Unchanged | 50 | 0 (0.0%) | 0 | $0 | 2022-11-10 | |
| Q2 2022 | Unchanged | 50 | 0 (0.0%) | 0 | $0 | 2022-08-01 | |
| Q1 2022 | Unchanged | 50 | 0 (0.0%) | 0 | $0 | 2022-04-28 | |
| Q4 2021 | Unchanged | 50 | 0 (0.0%) | 0 | $0 | 2022-01-20 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
3 managers reported KALA PHARMACEUTICALS INC. COM for Q2 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| HARBOUR INVESTMENTS INC | Unchanged | 3 | 0 | < 0.01% | $5 | 2 qtrs |
| Parallel Advisors LLC This report | Reduced | 0 | -1 | 0 | $0 | 22 qtrs |
| Cheviot Value Management LLC | Reduced | 0 | -153 | 0 | $0 | 6 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2026
- Filed
- August 05, 2026
- Filing type
- 13F-HR
- Position type
- Stock
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.